RUFF SHAMIM received a stock award from REATA PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 6/9/2023ACC: 0001209191-23-035879
+4.85K
Net shares
Net buyer
$200.0K
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
4.85K acquired
Non-Derivative Transactions2
Class A common stock
Direct
Shares
+454.00
Price / share
$93.61
Trade value
$42.50K
% of position
8.7%
6/7/2023
5.22K→5.68K
Class A common stock
Direct
Shares
+1.68K
Price / share
$93.61
Trade value
$157.45K
% of position
29.6%
6/7/2023
5.68K→7.36K
Total
Net shares
+2.14K
Net value
$199.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A common stock Direct | 6/7/2023 | A · Award | +454.00 | $93.61 | $42.50K | 8.7% | 5.22K | 5.68K |
| Class A common stock Direct | 6/7/2023 | A · Award | +1.68K | $93.61 | $157.45K | 29.6% | 5.68K | 7.36K |
| Total | +2.14K | $199.95K | ||||||
Derivative Transactions2
Stock Option (right-to-buy)
Direct
Converts to
Class A common stock
576.00 shares
Shares
+576.00
Strike price
93.61
Held after
576.00
Exercisable
—
6/7/2023
Stock Option (right-to-buy)
Direct
Converts to
Class A common stock
2.14K shares
Shares
+2.14K
Strike price
93.61
Held after
2.14K
Exercisable
—
6/7/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy) Direct | Class A common stock576.00 shares | 6/7/2023 | A · Award | +576.00 | 93.61 | — | 576.00 |
| Stock Option (right-to-buy) Direct | Class A common stock2.14K shares | 6/7/2023 | A · Award | +2.14K | 93.61 | — | 2.14K |